tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BMY Stock Latest News

Bristol-Myers Squibb’s Nivolumab Study: A Boost for Head and Neck Cancer Treatment
Company AnnouncementsBristol-Myers Squibb’s Nivolumab Study: A Boost for Head and Neck Cancer Treatment
24h ago
BMY
Bristol-Myers Squibb’s Ozanimod Study for Ulcerative Colitis: Market Implications of a Terminated Trial
PremiumCompany Announcements
Bristol-Myers Squibb’s Ozanimod Study for Ulcerative Colitis: Market Implications of a Terminated Trial
24h ago
BMY
Bristol-Myers Squibb’s New Study: A Potential Game Changer in Leukemia Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study: A Potential Game Changer in Leukemia Treatment
24h ago
BMY
Bristol-Myers Squibb’s Mavacamten Study: A Potential Game-Changer for Heart Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s Mavacamten Study: A Potential Game-Changer for Heart Treatment
24h ago
BMY
Bristol-Myers Squibb’s Completed Study on Deucravacitinib Formulations: Market Implications
PremiumCompany Announcements
Bristol-Myers Squibb’s Completed Study on Deucravacitinib Formulations: Market Implications
24h ago
BMY
Bristol-Myers Squibb’s Deucravacitinib Study: A Potential Game-Changer for Lupus Treatment
PremiumCompany AnnouncementsBristol-Myers Squibb’s Deucravacitinib Study: A Potential Game-Changer for Lupus Treatment
2d ago
BMY
Bristol-Myers Squibb’s Ozanimod Study: A Potential Game-Changer in Pediatric Ulcerative Colitis Treatment
Premium
Company Announcements
Bristol-Myers Squibb’s Ozanimod Study: A Potential Game-Changer in Pediatric Ulcerative Colitis Treatment
2d ago
BMY
Bristol-Myers Squibb’s Promising Phase 3 Study on Deucravacitinib for Sjögren’s Syndrome
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Phase 3 Study on Deucravacitinib for Sjögren’s Syndrome
3d ago
BMY
Bristol-Myers Squibb’s Ozanimod Study: Key Insights for Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s Ozanimod Study: Key Insights for Investors
3d ago
BMY
Bristol-Myers Squibb: Hold Rating Amid Slower Growth and Stable Valuation
PremiumRatings
Bristol-Myers Squibb: Hold Rating Amid Slower Growth and Stable Valuation
3d ago
BMY
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game-Changer?
PremiumCompany Announcements
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game-Changer?
6d ago
BMY
Bristol-Myers Squibb’s Anticoagulant Study: Key Insights for Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s Anticoagulant Study: Key Insights for Investors
6d ago
BMY
Bristol-Myers Squibb’s New Study on Izalontamab Brengitecan: A Potential Game-Changer in Breast Cancer Treatment
PremiumCompany AnnouncementsBristol-Myers Squibb’s New Study on Izalontamab Brengitecan: A Potential Game-Changer in Breast Cancer Treatment
6d ago
BMY
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game-Changer?
Premium
Company Announcements
Bristol-Myers Squibb’s New Alzheimer’s Study: A Potential Game-Changer?
6d ago
BMY
Bristol-Myers Squibb’s Promising Cancer Study: A Closer Look
Premium
Company Announcements
Bristol-Myers Squibb’s Promising Cancer Study: A Closer Look
6d ago
BMY
Bristol-Myers Squibb and ONO Pharmaceutical’s Promising Study on Gastric Cancer Treatment
PremiumCompany Announcements
Bristol-Myers Squibb and ONO Pharmaceutical’s Promising Study on Gastric Cancer Treatment
6d ago
BMY
Bristol-Myers Squibb’s Promising HFpEF Study: Key Insights for Investors
PremiumCompany Announcements
Bristol-Myers Squibb’s Promising HFpEF Study: Key Insights for Investors
6d ago
BMY
Bristol-Myers Squibb’s ELEMENT-MDS Trial: A Potential Game-Changer in Anemia Treatment
PremiumCompany Announcements
Bristol-Myers Squibb’s ELEMENT-MDS Trial: A Potential Game-Changer in Anemia Treatment
6d ago
BMY
Bristol-Myers Squibb’s New Study on Ozanimod: Implications for Pregnant Women with Ulcerative Colitis
PremiumCompany Announcements
Bristol-Myers Squibb’s New Study on Ozanimod: Implications for Pregnant Women with Ulcerative Colitis
6d ago
BMY
Bristol-Myers Squibb’s New Study on Belatacept Regimen for Adolescent Kidney Transplant Recipients
PremiumCompany AnnouncementsBristol-Myers Squibb’s New Study on Belatacept Regimen for Adolescent Kidney Transplant Recipients
6d ago
BMY
Bristol-Myers Squibb and ONO Pharmaceutical’s Nivolumab Study: A Market Game-Changer?
Premium
Company Announcements
Bristol-Myers Squibb and ONO Pharmaceutical’s Nivolumab Study: A Market Game-Changer?
6d ago
BMY
Bristol-Myers Squibb’s New Lung Cancer Trial: A Potential Game Changer?
Premium
Company Announcements
Bristol-Myers Squibb’s New Lung Cancer Trial: A Potential Game Changer?
6d ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >